Halo Labs launches Aura CL for cell therapy quality analysis

By The Science Advisory Board staff writers

April 20, 2021 -- Halo Labs has launched Aura CL, a next-generation instrument to measure cell therapy product quality.

The Aura CL distinguishes therapeutic cells from contaminants and other particles that might adversely harm patients.
The Aura CL distinguishes therapeutic cells from contaminants and other particles that might adversely harm patients. Image courtesy of Halo Labs.

Aura CL uses background membrane imaging and fluorescent membrane microscopy to distinguish therapeutic cells from contaminants and other particles that might affect product quality. The instrument can count, size, and identify therapeutic cell types and determine if nonconforming particles are cellular, protein, or other types of material, according to the firm.


Copyright © 2021 scienceboard.net
 

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?